V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330011496 | 330004290 | 1.75 | 24.9 | Curative (C) | 2017-08-02 | 2017-10-02 | MAP | N | N | 330011005 | MAP |
| 330011497 | 330004291 | null | null | Palliative (P) | null | 2016-06-02 | CETUXIMAB | null | null | 330011005 | CETUXIMAB |
| 330011498 | 330004294 | null | 55.2 | Curative (C) | 2013-06-22 | 2013-07-06 | PAM x 2 post-surgery (cycles 3&4) | N | N | 330011029 | MAP |
| 330011499 | 330004298 | 1.8 | 80 | Curative (C) | 2016-03-06 | 2016-04-04 | Rituximab (INTRAVENOUS Maintenance) | 2 | N | 330011043 | RITUXIMAB |
| 330011500 | 330004302 | 1.42 | 45.6 | null | 2013-03-11 | 2013-08-12 | OST Euramos 1 Closed Trial - M | Y | N | 330011097 | METHOTREXATE HIGH DOSE |
| 330011501 | 330004306 | 1.7 | 106.5 | Adjuvant (A) | 2016-05-11 | 2016-05-22 | Carboplatin AUC 6 - 10 | N | N | 330011174 | CARBOPLATIN |
| 330011502 | 330004306 | 1.68 | 44.45 | Palliative (P) | 2018-01-08 | 2018-01-10 | Etoposide + Ifosfamide (5 days) | N | null | 330011174 | ETOPOSIDE + IFOSFAMIDE |
| 330011503 | 330008357 | 1.81 | 71.8 | Curative (C) | 2013-12-23 | 2014-01-05 | CISPLATIN + FLUOROURACIL | N | N | 330011205 | CISPLATIN + FLUOROURACIL |
| 330011504 | 330004315 | 1.7 | 91.3 | Curative (C) | 2017-07-23 | 2017-08-11 | MAP | 99 | null | 330011267 | MAP |
| 330011505 | 330008360 | null | null | Disease modification (D) | null | 2018-07-21 | Rituximab | N | null | 330011276 | RITUXIMAB |
| 330011507 | 330004324 | 1.78 | null | Palliative (P) | null | 2017-12-05 | Carboplatin AUC 2 - 5 | N | null | 330011311 | CARBOPLATIN |
| 330011508 | 330004327 | null | 63.4 | Neo-adjuvant (N) | 2016-05-17 | 2016-07-30 | Cetuximab 7 day (>Cycle 2) | null | null | 330011340 | CETUXIMAB |
| 330011509 | 330008365 | 1.7 | 72.4 | Palliative (P) | 2013-11-23 | 2013-11-25 | Cisplatin +Fluorouracil (3 wk) | N | N | 330011341 | CISPLATIN + FLUOROURACIL |
| 330011510 | 330012420 | 1.58 | 66 | Neo-adjuvant (N) | 2015-09-22 | 2015-11-04 | CETUXIMAB | 02 | N | 330011387 | CETUXIMAB |
| 330011511 | 330008367 | 1.85 | 0 | Palliative (P) | 2018-01-03 | 2018-06-24 | CISPLATIN + FLUOROURACIL | 2 | N | 330011441 | CISPLATIN + FLUOROURACIL |
| 330011512 | 330008368 | 1.77 | 66.7 | Curative (C) | 2016-12-25 | 2016-12-26 | MAP | N | N | 330011449 | MAP |
| 330011513 | 330012803 | 1.58 | 51.3 | Neo-adjuvant (N) | 2016-02-04 | 2016-07-11 | CARBOPLATIN | 2 | N | 330011453 | CARBOPLATIN |
| 330011514 | 330004341 | 0 | 39.2 | Curative (C) | 2016-11-01 | 2016-11-27 | MAP | 2 | Y | 330011479 | MAP |
| 330011515 | 330012422 | 0 | 54.5 | Curative (C) | 2015-03-31 | 2015-07-21 | Etoposide + Ifosfamide (3 days) | null | null | 330011480 | ETOPOSIDE + IFOSFAMIDE |
| 330011516 | 330004347 | 0 | null | Curative (C) | 2014-05-06 | 2014-05-11 | MAP | null | null | 330011497 | MAP |
| 330011517 | 330008373 | 1.8 | 95.4 | Palliative (P) | 2014-04-13 | 2014-04-14 | Carboplatin AUC 6 - 10 | N | N | 330011499 | CARBOPLATIN |
| 330011518 | 330008375 | 1.68 | 63 | null | 2016-09-08 | 2017-09-09 | Docetaxel + Gemcitabine (prior RT) | 2 | N | 330011513 | DOCETAXEL + GEMCITABINE |
| 330011519 | 330004355 | 1.77 | 95 | Palliative (P) | 2014-11-06 | 2014-11-06 | PAM x 2 pre-surgery (cycles 1&2) | 2 | N | 330011517 | MAP |
| 330011520 | 330004359 | 1.6 | 56.9 | Curative (C) | 2014-03-10 | 2014-03-21 | OST Euramos 1 Closed Trial - M | N | N | 330011529 | METHOTREXATE HIGH DOSE |
| 330011521 | 330004365 | 1.65 | 68 | null | null | 2018-12-23 | CISPLATIN + FLUOROURACIL | N | N | 330011598 | CISPLATIN + FLUOROURACIL |
| 330011522 | 330010548 | null | 114.8 | Neo-adjuvant (N) | 2018-04-22 | 2018-11-04 | Rituximab | 1 | N | 330011603 | RITUXIMAB |
| 330011523 | 330010550 | 1.6 | 47.4 | Adjuvant (A) | 2016-11-11 | 2016-11-12 | Docetaxel + Gemcitabine (prior RT) | 02 | N | 330011606 | DOCETAXEL + GEMCITABINE |
| 330011524 | 330004373 | null | 60 | Adjuvant (A) | 2014-04-09 | 2014-04-12 | MAP | null | null | 330011640 | MAP |
| 330011525 | 330010551 | 1.71 | 62.1 | Palliative (P) | 2017-02-08 | 2017-04-23 | CETUXIMAB | N | N | 330011643 | CETUXIMAB |
| 330011526 | 330012424 | 1.6 | 38.4 | Adjuvant (A) | 2015-06-01 | 2015-06-05 | PAM x 2 post-surgery (cycles 3&4) | N | N | 330011654 | MAP |
| 330011527 | 330004377 | 1.67 | 90.8 | Palliative (P) | 2017-08-14 | 2017-08-30 | CISPLATIN + FLUOROURACIL | 02 | N | 330011658 | CISPLATIN + FLUOROURACIL |
| 330011528 | 330004380 | 1.63 | 0 | Curative (C) | 2015-03-27 | 2015-02-01 | Rituximab | 02 | null | 330011676 | RITUXIMAB |
| 330011529 | 330004381 | null | 58.5 | Curative (C) | 2014-10-05 | 2015-02-01 | OST Euramos 1 Closed Trial - M | 2 | N | 330011679 | METHOTREXATE HIGH DOSE |
| 330011530 | 330004382 | null | 68 | Curative (C) | null | 2014-05-22 | Docetaxel + Gemcitabine (prior RT) | N | N | 330011685 | DOCETAXEL + GEMCITABINE |
| 330011531 | 330004391 | 1.51 | 57.9 | Palliative (P) | 2015-11-26 | 2015-11-26 | Carboplatin AUC 6 - 10 | 02 | N | 330011730 | CARBOPLATIN |
| 330011532 | 330008394 | 1.64 | 71 | Neo-adjuvant (N) | 2015-01-04 | 2015-03-13 | Cisplatin +Fluorouracil (3 wk) | N | Y | 330011745 | CISPLATIN + FLUOROURACIL |
| 330011533 | 330008395 | 0 | null | Palliative (P) | 2017-04-21 | 2017-04-26 | Carboplatin AUC 6 - 10 | N | N | 330011757 | CARBOPLATIN |
| 330011534 | 330004397 | 1.69 | 0 | Palliative (P) | 2017-09-03 | 2017-09-03 | CISPLATIN + FLUOROURACIL | Y | N | 330011764 | CISPLATIN + FLUOROURACIL |
| 330011535 | 330004403 | 1.62 | 60.2 | Curative (C) | null | 2018-03-06 | CARBOPLATIN | 02 | null | 330011783 | CARBOPLATIN |
| 330011536 | 330004406 | 1.75 | 61 | null | 2014-07-03 | 2014-07-03 | CISPLATIN + FLUOROURACIL | N | Y | 330011786 | CISPLATIN + FLUOROURACIL |
| 330011537 | 330004409 | 1.76 | 85.4 | Palliative (P) | 2014-11-12 | 2015-01-29 | Methotrexate High Dose (3g/m2) | N | N | 330011787 | METHOTREXATE HIGH DOSE |
| 330011538 | 330004414 | null | 48.2 | Palliative (P) | 2017-01-09 | 2017-01-09 | CISPLATIN + FLUOROURACIL | Y | N | 330011813 | CISPLATIN + FLUOROURACIL |
| 330011539 | 330008408 | 1.59 | 68 | Palliative (P) | 2017-02-11 | 2017-03-01 | PAM x 2 pre-surgery (cycles 1&2) | 02 | Y | 330011825 | MAP |
| 330011540 | 330004422 | 1.72 | 68 | Adjuvant (A) | 2016-08-08 | 2016-09-05 | CARBOPLATIN | 02 | N | 330011841 | CARBOPLATIN |
| 330011541 | 330012427 | null | 71.8 | Palliative (P) | 2015-10-30 | 2015-11-11 | Rituximab (INTRAVENOUS Maintenance) | 2 | N | 330011849 | RITUXIMAB |
| 330011542 | 330004424 | 1.77 | 68.9 | Curative (C) | 2016-02-22 | 2016-04-04 | Carboplatin AUC 2 - 5 | N | N | 330011872 | CARBOPLATIN |
| 330011543 | 330004431 | 1.77 | 88 | Not known (9) | 2016-05-07 | 2016-05-11 | CARBOPLATIN + ETOPOSIDE | N | Y | 330011916 | CARBOPLATIN + ETOPOSIDE |
| 330011544 | 330010563 | 1.79 | 65 | Curative (C) | 2013-11-25 | 2014-02-03 | CARBOPLATIN + RT | 02 | N | 330011931 | CARBOPLATIN + RT |
| 330011545 | 330013169 | null | null | Curative (C) | null | 2017-04-29 | ALL UKALL2011 Cap Int Maint C PAsp | Y | null | 330011940 | UKALL2011 |
| 330011546 | 330004436 | 1.68 | 57 | Curative (C) | null | 2019-03-28 | Cetuximab + Radiotherapy Maint | null | null | 330011956 | CETUXIMAB + RT |